Free shipping on all domestic orders over $39

FDA reviews Botox rival

Is a Solution for:
Sagging Skin
May 27, 2008 Reviewed by Marta 0 Comments
The FDA has agreed to review a European botulism toxin product that, if approved, would compete with Botox. The new face freezer is made by a French drug company called Ipsen and is licensed in 23 countries. If it gets the go-head it will be marketed under the name of Reloxin and will be, more or less, the same kind of poison as in Botox and is likely to raise the same safety concerns - recent animal tests on Botox revealed that it can seep to the brain. Last year Allergan, which owns the Botox patent, sold over $1 billion worth of the product.

Join the discussion! Leave a comment below.

My Comment

Add a comment...

-or- Cancel Comment
* Required Fields
truth in aging's five best

Truth In Aging's Five Best

The very best to choose from for your skin concerns.

Read More

truth in aging videos

Truth In Aging Videos

Helpful how-tos and reviews from Marta and friends.

Watch Now

meet our contributors

Meet Our Contributors

The TIA community consists of our trusted reviewers.

Meet Them

be inspired

Be Inspired

Inspiring thoughts and women who are aging gracefully.

Read More